Semin Reprod Med 2023; 41(03/04): 87-96
DOI: 10.1055/s-0043-1776420
Review Article

Obesity and In Vitro Fertilization

Emily L. Ferrell
1   Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan
,
Abira A. Choudhry
2   University of Michigan Medical School, Ann Arbor, Michigan
,
Samantha B. Schon
1   Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan
› Institutsangaben
› Weitere Informationen
   Lizenzen und Reprints

Abstract

Obesity is a highly prevalent chronic disease with a significant effect on reproductive-age women. The clinical implications of obesity on fertility and pregnancy are well studied citing ovulatory dysfunction, hormonal imbalances, higher miscarriage rates, and increased maternal and neonatal risks. For this reason, many patients with obesity seek reproductive specialists to help build their families. Despite this literature base, the effect of weight loss interventions prior to assisted reproductive technology (ART) is lacking. This review aims to outline the impact of obesity on ART, specifically in vitro fertilization (IVF). Response differences to treatment protocols compared with normal weight counterparts, limitations of access to care, and the mixed results of weight-reduction strategies prior to fertility treatment will be addressed. The known data surrounding benefits of lifestyle modification, pharmacologic therapies, and surgical interventions for obesity prior to IVF are outlined and found to emphasize a need for further research to determine the optimal approach for infertility patients with obesity.

Keywords

obesity - in vitro fertilization - assisted reproductive technology - infertility


Publikationsverlauf

Artikel online veröffentlicht:
01. November 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017-2018. NCHS Data Brief 2020; (360) 1-8
    PubMedGoogle Scholar
  • 2 Driscoll AK, Gregory ECW. Increases in prepregnancy obesity: United States, 2016-2019. NCHS Data Brief 2020; (392) 1-8
    PubMedGoogle Scholar
  • 3 Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Obesity and reproduction: a committee opinion. Fertil Steril 2021; 116 (05) 1266-1285
    CrossrefPubMedGoogle Scholar
  • 4 Obesity in pregnancy: ACOG Practice Bulletin, Number 230. Obstet Gynecol 2021; 137 (06) e128-e144
    CrossrefPubMedGoogle Scholar
  • 5 World Health Organization. Infertility. Published April 3, 2023. Accessed October 13, 2023 at: https://www.who.int/news-room/fact-sheets/detail/infertility
    PubMedGoogle Scholar
  • 6 Wise LA, Rothman KJ, Mikkelsen EM, Sørensen HT, Riis A, Hatch EE. An internet-based prospective study of body size and time-to-pregnancy. Hum Reprod 2010; 25 (01) 253-264
    CrossrefPubMedGoogle Scholar
  • 7 Itriyeva K. The effects of obesity on the menstrual cycle. Curr Probl Pediatr Adolesc Health Care 2022; 52 (08) 101241
    CrossrefPubMedGoogle Scholar
  • 8 Wang P, Mariman E, Renes J, Keijer J. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol 2008; 216 (01) 3-13
    CrossrefPubMedGoogle Scholar
  • 9 Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol 2018; 16 (01) 22
    CrossrefPubMedGoogle Scholar
  • 10 Tersigni C, Di Nicuolo F, D'Ippolito S, Veglia M, Castellucci M, Di Simone N. Adipokines: new emerging roles in fertility and reproduction. Obstet Gynecol Surv 2011; 66 (01) 47-63
    CrossrefPubMedGoogle Scholar
  • 11 Dos Santos E, Serazin V, Morvan C. et al. Adiponectin and leptin systems in human endometrium during window of implantation. Fertil Steril 2012; 97 (03) 771-8.e1
    CrossrefPubMedGoogle Scholar
  • 12 Kawano J, Arora R. The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr 2009; 4 (01). DOI: 10.1111/j.1559-4572.2008.00030.x.
    CrossrefPubMedGoogle Scholar
  • 13 Shi M, Sirard MA. Metabolism of fatty acids in follicular cells, oocytes, and blastocysts. Reprod Fertil 2022; 3 (02) R96-R108
    CrossrefPubMedGoogle Scholar
  • 14 Wołodko K, Castillo-Fernandez J, Kelsey G, Galvão A. Revisiting the impact of local leptin signaling in folliculogenesis and oocyte maturation in obese mothers. Int J Mol Sci 2021; 22 (08) 4270
    CrossrefPubMedGoogle Scholar
  • 15 Gautam D, Purandare N, Maxwell CV. et al; FIGO Committee on Impact of Pregnancy on Long-term Health and the FIGO Committee on Reproductive Medicine, Endocrinology and Infertility. The challenges of obesity for fertility: a FIGO literature review. Int J Gynaecol Obstet 2023; 160 (Suppl 1, Suppl 1): 50-55
    CrossrefPubMedGoogle Scholar
  • 16 Sermondade N, Huberlant S, Bourhis-Lefebvre V. et al. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update 2019; 25 (04) 439-451
    CrossrefPubMedGoogle Scholar
  • 17 Souter I, Baltagi LM, Kuleta D, Meeker JD, Petrozza JC. Women, weight, and fertility: the effect of body mass index on the outcome of superovulation/intrauterine insemination cycles. Fertil Steril 2011; 95 (03) 1042-1047
    CrossrefPubMedGoogle Scholar
  • 18 Wittemer C, Ohl J, Bailly M, Bettahar-Lebugle K, Nisand I. Does body mass index of infertile women have an impact on IVF procedure and outcome?. J Assist Reprod Genet 2000; 17 (10) 547-552
    CrossrefPubMedGoogle Scholar
  • 19 Tamer Erel C, Senturk LM. The impact of body mass index on assisted reproduction. Curr Opin Obstet Gynecol 2009; 21 (03) 228-235
    CrossrefPubMedGoogle Scholar
  • 20 Fedorcsák P, Dale PO, Storeng R. et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 2004; 19 (11) 2523-2528
    CrossrefPubMedGoogle Scholar
  • 21 Kim J, Patounakis G, Juneau C. et al. The Appraisal of Body Content (ABC) trial: Increased male or female adiposity does not significantly impact in vitro fertilization laboratory or clinical outcomes. Fertil Steril 2021; 116 (02) 444-452
    CrossrefPubMedGoogle Scholar
  • 22 Bernardi LA, Carnethon MR, de Chavez PJ. et al. Relationship between obesity and anti-Müllerian hormone in reproductive-aged African American women. Obesity (Silver Spring) 2017; 25 (01) 229-235
    CrossrefPubMedGoogle Scholar
  • 23 Shah DK, Missmer SA, Berry KF, Racowsky C, Ginsburg ES. Effect of obesity on oocyte and embryo quality in women undergoing in vitro fertilization. Obstet Gynecol 2011; 118 (01) 63-70
    CrossrefPubMedGoogle Scholar
  • 24 Schon SB, Yang K, Schindler R. et al. Obesity-related alterations in protein expression in human follicular fluid from women undergoing in vitro fertilization. F S Sci 2022; 3 (04) 331-339
    PubMedGoogle Scholar
  • 25 Gonzalez MB, Lane M, Knight EJ, Robker RL. Inflammatory markers in human follicular fluid correlate with lipid levels and Body Mass Index. J Reprod Immunol 2018; 130: 25-29
    CrossrefPubMedGoogle Scholar
  • 26 Robker RL, Akison LK, Bennett BD. et al. Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderate-weight women. J Clin Endocrinol Metab 2009; 94 (05) 1533-1540
    CrossrefPubMedGoogle Scholar
  • 27 Jungheim ES, Lanzendorf SE, Odem RR, Moley KH, Chang AS, Ratts VS. Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome. Fertil Steril 2009; 92 (01) 256-261
    CrossrefPubMedGoogle Scholar
  • 28 Coyne K, Whigham LD, O'Leary K, Yaklic JK, Maxwell RA, Lindheim SR. Gestational carrier BMI and reproductive, fetal and neonatal outcomes: are the risks the same with increasing obesity?. Int J Obes 2016; 40 (01) 171-175
    CrossrefPubMedGoogle Scholar
  • 29 Jungheim ES, Moley KH. Current knowledge of obesity's effects in the pre- and periconceptional periods and avenues for future research. Am J Obstet Gynecol 2010; 203 (06) 525-530
    CrossrefPubMedGoogle Scholar
  • 30 Rittenberg V, Sobaleva S, Ahmad A. et al. Influence of BMI on risk of miscarriage after single blastocyst transfer. Hum Reprod 2011; 26 (10) 2642-2650
    CrossrefPubMedGoogle Scholar
  • 31 Metwally M, Cutting R, Tipton A, Skull J, Ledger WL, Li TC. Effect of increased body mass index on oocyte and embryo quality in IVF patients. Reprod Biomed Online 2007; 15 (05) 532-538
    CrossrefPubMedGoogle Scholar
  • 32 Goldman KN, Hodes-Wertz B, McCulloh DH, Flom JD, Grifo JA. Association of body mass index with embryonic aneuploidy. Fertil Steril 2015; 103 (03) 744-748
    CrossrefPubMedGoogle Scholar
  • 33 Boots CE, Bernardi LA, Stephenson MD. Frequency of euploid miscarriage is increased in obese women with recurrent early pregnancy loss. Fertil Steril 2014; 102 (02) 455-459
    CrossrefPubMedGoogle Scholar
  • 34 Lee JC, Bernardi LA, Boots CE. The association of euploid miscarriage with obesity. F S Rep 2020; 1 (02) 142-148
    PubMedGoogle Scholar
  • 35 Wise MR, Jordan V, Lagas A. et al. Obesity and endometrial hyperplasia and cancer in premenopausal women: a systematic review. Am J Obstet Gynecol 2016; 214 (06) 689.e1-689.e17
    CrossrefPubMedGoogle Scholar
  • 36 Bellver J, Martínez-Conejero JA, Labarta E. et al. Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome. Fertil Steril 2011; 95 (07) 2335-2341 , 2341.e1–2341.e8
    CrossrefPubMedGoogle Scholar
  • 37 Bellver J, Pellicer A, García-Velasco JA, Ballesteros A, Remohí J, Meseguer M. Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors. Fertil Steril 2013; 100 (04) 1050-1058
    CrossrefPubMedGoogle Scholar
  • 38 Pinborg A, Gaarslev C, Hougaard CO. et al. Influence of female bodyweight on IVF outcome: a longitudinal multicentre cohort study of 487 infertile couples. Reprod Biomed Online 2011; 23 (04) 490-499
    CrossrefPubMedGoogle Scholar
  • 39 Luke B, Brown MB, Stern JE, Missmer SA, Fujimoto VY, Leach R. SART Writing Group. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod 2011; 26 (01) 245-252
    CrossrefPubMedGoogle Scholar
  • 40 Petersen GL, Schmidt L, Pinborg A, Kamper-Jørgensen M. The influence of female and male body mass index on live births after assisted reproductive technology treatment: a nationwide register-based cohort study. Fertil Steril 2013; 99 (06) 1654-1662
    CrossrefPubMedGoogle Scholar
  • 41 Moragianni VA, Jones SML, Ryley DA. The effect of body mass index on the outcomes of first assisted reproductive technology cycles. Fertil Steril 2012; 98 (01) 102-108
    CrossrefPubMedGoogle Scholar
  • 42 Provost MP, Acharya KS, Acharya CR. et al. Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008-2010 Society for Assisted Reproductive Technology registry. Fertil Steril 2016; 105 (03) 663-669
    CrossrefPubMedGoogle Scholar
  • 43 Akpınar F, Demir B, Dilbaz S, Kaplanoğlu I, Dilbaz B. Obesity is not associated with the poor pregnancy outcome following intracytoplasmic sperm injection in women with polycystic ovary syndrome. J Turk Ger Gynecol Assoc 2014; 15 (03) 144-148
    CrossrefPubMedGoogle Scholar
  • 44 Kaye L, Sueldo C, Engmann L, Nulsen J, Benadiva C. Survey assessing obesity policies for assisted reproductive technology in the United States. Fertil Steril 2016; 105 (03) 703-706.e2
    CrossrefPubMedGoogle Scholar
  • 45 Gillett WR, Peek JC, Herbison GP. Development of clinical priority access criteria for assisted reproduction and its evaluation on 1386 infertile couples in New Zealand. Hum Reprod 2012; 27 (01) 131-141
    CrossrefPubMedGoogle Scholar
  • 46 Balen AH, Anderson RA. Policy & Practice Committee of the BFS. Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines. Hum Fertil (Camb) 2007; 10 (04) 195-206
    CrossrefPubMedGoogle Scholar
  • 47 Turner-McGrievy GM, Grant BL. Prevalence of body mass index and body weight cut-off points for in vitro fertilization treatment at U.S. clinics and current clinic weight loss strategy recommendations. Hum Fertil (Camb) 2015; 18 (03) 215-219
    CrossrefPubMedGoogle Scholar
  • 48 Kelley AS, Badon SE, Lanham MSM, Fisseha S, Moravek MB. Body mass index restrictions in fertility treatment: a national survey of OB/GYN subspecialists. J Assist Reprod Genet 2019; 36 (06) 1117-1125
    CrossrefPubMedGoogle Scholar
  • 49 Romanski PA, Farland LV, Tsen LC, Ginsburg ES, Lewis EI. Effect of class III and class IV obesity on oocyte retrieval complications and outcomes. Fertil Steril 2019; 111 (02) 294-301.e1
    CrossrefPubMedGoogle Scholar
  • 50 Petersen R, Pan L, Blanck HM. Racial and ethnic disparities in adult obesity in the United States: CDC's tracking to inform state and local action. Prev Chronic Dis 2019; 16: E46
    CrossrefPubMedGoogle Scholar
  • 51 Slocum B, Schon SB. Body size, fertility, and reproductive justice: examining the complex interplay between BMI, reproductive health, and access to care. Women 2022; 2 (02) 93-101
    CrossrefPubMedGoogle Scholar
  • 52 Chavarro JE, Ehrlich S, Colaci DS. et al. Body mass index and short-term weight change in relation to treatment outcomes in women undergoing assisted reproduction. Fertil Steril 2012; 98 (01) 109-116
    CrossrefPubMedGoogle Scholar
  • 53 Sim KA, Dezarnaulds GM, Denyer GS, Skilton MR, Caterson ID. Weight loss improves reproductive outcomes in obese women undergoing fertility treatment: a randomized controlled trial. Clin Obes 2014; 4 (02) 61-68
    CrossrefPubMedGoogle Scholar
  • 54 Espinós JJ, Polo A, Sánchez-Hernández J. et al. Weight decrease improves live birth rates in obese women undergoing IVF: a pilot study. Reprod Biomed Online 2017; 35 (04) 417-424
    CrossrefPubMedGoogle Scholar
  • 55 Wu L, Fang Q, Wang M. et al. Effect of weight loss on pregnancy outcomes, neuronal-reproductive-metabolic hormones and gene expression profiles in granulosa cells in obese infertile PCOS patients undergoing IVF-ET. Front Endocrinol (Lausanne) 2022; 13: 954428
    CrossrefPubMedGoogle Scholar
  • 56 Moran L, Tsagareli V, Norman R, Noakes M. Diet and IVF pilot study: short-term weight loss improves pregnancy rates in overweight/obese women undertaking IVF. Aust N Z J Obstet Gynaecol 2011; 51 (05) 455-459
    CrossrefPubMedGoogle Scholar
  • 57 Einarsson S, Bergh C, Friberg B. et al. Weight reduction intervention for obese infertile women prior to IVF: a randomized controlled trial. Hum Reprod 2017; 32 (08) 1621-1630
    CrossrefPubMedGoogle Scholar
  • 58 Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA 2014; 311 (01) 74-86
    CrossrefPubMedGoogle Scholar
  • 59 Novograd J, Mullally J, Frishman WH. Semaglutide for weight loss: Was it worth the weight?. Cardiol Rev 2022; 30 (06) 324-329
    CrossrefPubMedGoogle Scholar
  • 60 Wang Z, Zhao J, Ma X. et al. Effect of orlistat on live birth rate in overweight or obese women undergoing IVF-ET: a randomized clinical trial. J Clin Endocrinol Metab 2021; 106 (09) e3533-e3545
    CrossrefPubMedGoogle Scholar
  • 61 Tong J, Xiang L, Niu Y, Zhang T. Effect of orlistat intervention on in vitro fertilization/intracytoplasmic sperm injection outcome in overweight/obese infertile women. Gynecol Endocrinol 2022; 38 (03) 253-257
    CrossrefPubMedGoogle Scholar
  • 62 Aronne LJ, Wadden TA, Peterson C, Winslow D, Odeh S, Gadde KM. Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults. Obesity (Silver Spring) 2013; 21 (11) 2163-2171
    CrossrefPubMedGoogle Scholar
  • 63 Khera R, Murad MH, Chandar AK. et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA 2016; 315 (22) 2424-2434
    CrossrefPubMedGoogle Scholar
  • 64 Vitek WS, Hoeger KM. Worth the wait? Preconception weight reduction in women and men with obesity and infertility: a narrative review. Fertil Steril 2022; 118 (03) 447-455
    CrossrefPubMedGoogle Scholar
  • 65 Chao AM, Tronieri JS, Amaro A, Wadden TA. Semaglutide for the treatment of obesity. Trends Cardiovasc Med 2023; 33 (03) 159-166
    CrossrefPubMedGoogle Scholar
  • 66 O'Neil PM, Birkenfeld AL, McGowan B. et al. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet 2018; 392 (10148): 637-649
    CrossrefPubMedGoogle Scholar
  • 67 Wilding JPH, Batterham RL, Calanna S. et al; STEP 1 Study Group. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 2021; 384 (11) 989-1002
    CrossrefPubMedGoogle Scholar
  • 68 Salamun V, Jensterle M, Janez A, Vrtacnik Bokal E. Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. Eur J Endocrinol 2018; 179 (01) 1-11
    CrossrefPubMedGoogle Scholar
  • 69 Gosman GG, King WC, Schrope B. et al. Reproductive health of women electing bariatric surgery. Fertil Steril 2010; 94 (04) 1426-1431
    CrossrefPubMedGoogle Scholar
  • 70 Estimate of Bariatric Surgery Numbers. 2011–2021. American Society for Metabolic and Bariatric Surgery; . Published June 27, 2022. Accessed August 13, 2023 at: https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers
    Google Scholar
  • 71 Milone M, De Placido G, Musella M. et al. Incidence of successful pregnancy after weight loss interventions in infertile women: a systematic review and meta-analysis of the literature. Obes Surg 2016; 26 (02) 443-451
    CrossrefPubMedGoogle Scholar
  • 72 Tsur A, Orvieto R, Haas J, Kedem A, Machtinger R. Does bariatric surgery improve ovarian stimulation characteristics, oocyte yield, or embryo quality?. J Ovarian Res 2014; 7: 116
    CrossrefPubMedGoogle Scholar
  • 73 Milone M, Sosa Fernandez LM, Sosa Fernandez LV. et al. Does bariatric surgery improve assisted reproductive technology outcomes in obese infertile women?. Obes Surg 2017; 27 (08) 2106-2112
    CrossrefPubMedGoogle Scholar
  • 74 Grzegorczyk-Martin V, Fréour T, De Bantel Finet A. et al. IVF outcomes in patients with a history of bariatric surgery: a multicenter retrospective cohort study. Hum Reprod 2020; 35 (12) 2755-2762
    CrossrefPubMedGoogle Scholar
  • 75 Nilsson-Condori E, Mattsson K, Thurin-Kjellberg A, Hedenbro JL, Friberg B. Outcomes of in-vitro fertilization after bariatric surgery: a national register-based case-control study. Hum Reprod 2022; 37 (10) 2474-2481
    CrossrefPubMedGoogle Scholar